APA (7th ed.) Citation

TWR, H., CA, A., & JF, W. (2022). International guidelines regarding the role of intravenous immunoglobulin in the management of RhD- and ABO-mediated haemolytic disease of the newborn-reconsidering the recommendations. British journal of haematology, 199(3), 452. https://doi.org/10.1111/bjh.18421

Chicago Style (17th ed.) Citation

TWR, Hansen, Akkök CA, and Watchko JF. "International Guidelines Regarding the Role of Intravenous Immunoglobulin in the Management of RhD- and ABO-mediated Haemolytic Disease of the Newborn-reconsidering the Recommendations." British Journal of Haematology 199, no. 3 (2022): 452. https://doi.org/10.1111/bjh.18421.

MLA (9th ed.) Citation

TWR, Hansen, et al. "International Guidelines Regarding the Role of Intravenous Immunoglobulin in the Management of RhD- and ABO-mediated Haemolytic Disease of the Newborn-reconsidering the Recommendations." British Journal of Haematology, vol. 199, no. 3, 2022, p. 452, https://doi.org/10.1111/bjh.18421.